Titre:
  • Prevention and management of major side effects of targeted agents in breast cancer.
Auteur:Metzger Filho, Otto; Saini, Kamal; Abdel Azim, Hatem Hamdy; Awada, Ahmad; Association of Radiotherapy and Oncology of the Mediterranean arEa (AROME),
Informations sur la publication:Critical reviews in oncology/hematology, 84 Suppl 1, page (e79-e85)
Statut de publication:Publié, 2012-12
Sujet CREF:Cancérologie
Mots-clés:Bevacizumab
Lapatinib
Management incidence
Prevention
Targeted therapy
Toxicity
Trastuzumab
MeSH keywords:Animals
Antibodies, Monoclonal, Humanized -- adverse effects
Antineoplastic Agents -- adverse effects
Breast -- drug effects
Breast Neoplasms -- drug therapy
Cardiovascular Diseases -- chemically induced -- prevention & control
Female
Gastrointestinal Diseases -- chemically induced -- prevention & control
Humans
Molecular Targeted Therapy -- methods
Quinazolines -- adverse effects
Skin Diseases -- chemically induced -- prevention & control
Note générale:Journal Article
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1040-8428
info:doi/10.1016/j.critrevonc.2010.07.014
info:pii/S1040-8428(10)00181-2
info:scp/84871681602
info:pmid/20817545